Cancer drug Toripalimab that treats aggressive form of head and neck cancer launched in India
IANS Dr. Reddy's Laboratories has announced the launch of Toripalimab in India. This drug is designed to treat adults suffering from Nasopharyngeal carcinoma (NPC), a rare and aggressive form of head and neck cancer that originates in the nasopharynx, …